Showing 1 - 4 of 4 ATRIAL FIBRILLATION

Status: Open Not Enrolling

Investigator: Sherman Tang

Study Coordinator: Sheila Moore

Phone: 281.274.8062

In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purpose ... Read more >

Status: Enrolling

Investigator: Mahendra Jain

Study Coordinator: Bela Jain

Phone: 281.485.3434

In patients with diabetes and high triglycerides, subjects will be given pemafibrate to help reduce triglycerides level and cardiovascular outcomes. ... Read more >

Status: Open Not Enrolling

Investigator: Miguel Valderrabano

Study Coordinator: Michelle Prystash

Phone: 713.441.6564

The broad, long-term objective of this project is to evaluate the therapeutic value of vein of Marshall (VOM) ethanol infusion when added to catheter ablation of atrial fibrillation (AF). AF is the most common sustained arrhythmia in adults, and ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: Patricia Brinegar

Phone: 713.441.3506

The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transca ... Read more >

Live Chat Available